Relation between red cell distribution width and clinical outcome after surgery for congenital heart disease in children

Pediatric Cardiology

Volumn 33, Issue 7, 2012, Pages 1021-1025

  Massin, Martial M ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

Congenital heart disease; Heart failure; Red cell distribution width; Surgical outcome

Indexed keywords

ANEMIA; ARTICLE; CELLULAR DISTRIBUTION; CHILD; CONGENITAL HEART DISEASE; ERYTHROCYTE; ERYTHROCYTE DISTRIBUTION WIDTH; FEMALE; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; OPEN HEART SURGERY; PRESCHOOL CHILD; SURGICAL MORTALITY;

ADOLESCENT; ANALYSIS OF VARIANCE; CHILD; CHILD, PRESCHOOL; ERYTHROCYTE INDICES; ERYTHROCYTES; FEMALE; HEART DEFECTS, CONGENITAL; HUMANS; INFANT; LENGTH OF STAY; MALE; RISK ASSESSMENT; RISK FACTORS; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME;

EID: 84867892098     PISSN: 01720643     EISSN: 14321971     Source Type: Journal    
DOI: 10.1007/s00246-012-0220-0     Document Type: Article

References (15)

1. Allen LA, Felker GM, Mehra MR, Chiong JR, Dunlap SH, Ghali JK, Lenihan DJ, Oren RM, Wagoner LE, Schwartz TA, Adams KF Jr. (2010) Validation and potential mechanisms of red cell distribution width as a prognostic marker in heart failure. J Cardiac Fail 16:230-238
2. Cavusoglu E, Chopra V, Gupta A, Battala VR, Poludasu S, Eng C, Marmur JD (2010) Relation between red blood cell distribution width and all-cause mortality at two years in an unselected population referred for coronary angiography. Int J Cardiol 141:141-146
3. Dabbah S, Hammerman H, Markiewicz W, Aronson D (2010) Relation between red cell distribution width and clinical outcomes after acute myocardial infarction. Am J Cardiol 105:312-317
4. Deswal A, Petersen NJ, Feldman AM, Young JB, White BG, Mann DL (2001) Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the Vesnarinone trial (VEST). Circulation 103:2055-2059
5. Felker GM, Allen LA, Pocock SJ, Shaw LK, McMurray JJV, Pfeiffer MA, Swedberg K, Wang D, Yusuf S, Michelson EL, Granger CB, for the CHARM investigators (2007) Red cell distribution width as a novel prognostic marker in heart failure: data from the CHARM Program and the Duke Databank. J Am Coll Cardiol 50:40-47
6. Forhécz Z, Gombos T, Borgulya G, Pozsonyi Z, Prohaszka Z, Janoskuti L (2009) Red cell distribution width in heart failure: prediction of clinical events and relationship with markers of ineffective erythropoiesis, inflammation, renal function, and nutritional state. Am Heart J 158:659-666
7. Gossmann J, Burkhardt R, Harder S, Lenz T, Sedlmeyer A, Klinkhardt U, Geiger H, Scheuermann EH (2001) Angiotensin II infusion increases plasma erythropoietin levels via an angiotensin II type 1 receptor-dependent pathway. Kidney Int 60:83-86
8. Hampole CV, Mehrotra AK, Thenappan T, Gomberg-Maitland M, Shah SJ (2009) Usefulness of red cell distribution width as a prognostic marker in pulmonary hypertension. Am J Cardiol 104:868-872
9. Levine B, Kalman J, Mayer L, Fillit HM, Packer M (1990) Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Eng J Med 323:236-241
10. Mladenovic J, Adamson JW (1984) Adrenergic modulation of erythropoiesis: in vitro studies of colony-forming cells in normal and polycythaemic man. Br J Haematol 56:323-332
11. Munger MA, Johnson B, Amber IJ, Callahan KS, Gilbert EM (1996) Circulating concentrations of proinflammatory cytokines in mild or moderate heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 77:723-727
12. Pierce CN, Larson DF (2005) Inflammatory cytokine inhibition of erythropoiesis in patients implanted with a mechanical circulatory assist device. Perfusion 20:83-90
13. Tonelli M, Sacks F, Arnold M, Moye L, Davis B, Pfeffer M, for the Cholesterol and Recurrent Events (CARE) Trial Investigators (2008) Relation between red blood cell distribution width and cardiovascular event rate in people with coronary disease. Circulation 117:163-168
14. Torre-Amione G, Anker SD, Bourge RC, Colucci WS, Greenberg BH, Hildebrandt P, Keren A, Motro M, Moyé LA, Otterstad JE, Pratt CM, Ponikowski P, Rouleau JL, Sestier F, Winkelmann BR, Young JB, Advanced Chronic Heart Failure CLinical Assessment of Immune Modulation Therapy Investigators (2008) Results of a nonspecific immunomodulation therapy in chronic heart failure (ACCLAIM trial): a placebo-controlled randomised trial. Lancet 371:228-236
15. World Health Organization (2001) Iron deficiency anaemia: assessment, prevention, and control: a guide for programme managers. World Health Organization, Geneva (WHO/NHD/01.3)